Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Biological Chemistry
|
February 6, 2013
The regulation, localization, and functions of oxygen-sensing prolyl hydroxylase PHD3
Panu M Jaakkola, Krista Rantanen
Nucleic Acids Research
|
August 13, 2015
ROTS: reproducible RNA-seq biomarker detector-prognostic markers for clear cell renal cell cancer
Fatemeh Seyednasrollah, Krista Rantanen, Panu Jaakkola, et al.
Plos One
|
November 17, 2011
Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells
Heidi Högel, Krista Rantanen, Terhi Jokilehto, et al.
Molecular Biology of the Cell
|
March 14, 2008
Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation
Krista Rantanen, Juha Pursiheimo, Heidi Högel, et al.
Journal of Cell Science
|
January 25, 2013
p62/SQSTM1 regulates cellular oxygen sensing by attenuating PHD3 activity through aggregate sequestration and enhanced degradation
Krista Rantanen, Juha-Pekka Pursiheimo, Heidi Högel, et al.
The Journal of Biological Chemistry
|
January 9, 2019
Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high <i>HIF2A</i> mRNA levels in clear cell renal cell carcinoma
Petra Miikkulainen, Heidi Högel, Fatemeh Seyednasrollah, et al.
Experimental Cell Research
|
February 17, 2010
Retention of prolyl hydroxylase PHD2 in the cytoplasm prevents PHD2-induced anchorage-independent carcinoma cell growth
Terhi Jokilehto, Heidi Högel, Pekka Heikkinen, et al.
Cancer & Metabolism
|
July 7, 2017
HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
Petra Miikkulainen, Heidi Högel, Krista Rantanen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2006
Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness
Terhi Jokilehto, Krista Rantanen, Marjaana Luukkaa, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Biological Chemistry
|
February 6, 2013
The regulation, localization, and functions of oxygen-sensing prolyl hydroxylase PHD3
Panu M Jaakkola, Krista Rantanen
Nucleic Acids Research
|
August 13, 2015
ROTS: reproducible RNA-seq biomarker detector-prognostic markers for clear cell renal cell cancer
Fatemeh Seyednasrollah, Krista Rantanen, Panu Jaakkola, et al.
Plos One
|
November 17, 2011
Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells
Heidi Högel, Krista Rantanen, Terhi Jokilehto, et al.
Molecular Biology of the Cell
|
March 14, 2008
Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation
Krista Rantanen, Juha Pursiheimo, Heidi Högel, et al.
Journal of Cell Science
|
January 25, 2013
p62/SQSTM1 regulates cellular oxygen sensing by attenuating PHD3 activity through aggregate sequestration and enhanced degradation
Krista Rantanen, Juha-Pekka Pursiheimo, Heidi Högel, et al.
The Journal of Biological Chemistry
|
January 9, 2019
Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high <i>HIF2A</i> mRNA levels in clear cell renal cell carcinoma
Petra Miikkulainen, Heidi Högel, Fatemeh Seyednasrollah, et al.
Experimental Cell Research
|
February 17, 2010
Retention of prolyl hydroxylase PHD2 in the cytoplasm prevents PHD2-induced anchorage-independent carcinoma cell growth
Terhi Jokilehto, Heidi Högel, Pekka Heikkinen, et al.
Cancer & Metabolism
|
July 7, 2017
HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
Petra Miikkulainen, Heidi Högel, Krista Rantanen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2006
Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness
Terhi Jokilehto, Krista Rantanen, Marjaana Luukkaa, et al.
Page
of 1